Little Peptide, Big Effects: the Role of LL-37 in Inflammation and Autoimmune Disease

Overview

Journal J Immunol

Specialty Allergy & Immunology

Date 2013 Nov 5

PMID 24185823

Citations 182

Authors

J Michelle Kahlenberg

Mariana J Kaplan

Affiliations

Soon will be listed here.

Abstract

The innate immune system utilizes many approaches for defense against invading microorganisms, including complement-mediated lysis, engulfment, formation of neutrophil extracellular traps, and release of antimicrobial peptides. Although classically thought to be driven by adaptive immunity, the development of autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus is increasingly associated with dysregulated innate immune pathways. An emerging theme within this literature is the contribution of antimicrobial peptides to the development of autoimmune disorders. This is best exemplified in atopic dermatitis and psoriasis where the defensins and the single human cathelicidin, LL-37, may contribute to disease. Furthermore, in the past few years, a role for LL-37 has emerged in the pathogenesis of systemic lupus erythematosus, rheumatoid arthritis, atherosclerosis, and possibly other diseases. In this review, we discuss the role of LL-37 and its murine ortholog, mCRAMP, in the modulation of immune and inflammatory pathways and their effects on autoimmune and inflammatory diseases.

Citing Articles

Characterization of Novel Plantaricin-Derived Antiviral Peptides Against Flaviviruses.

Omer A, Kumar S, Selegard R, Bengtsson T, Khalaf H Int J Mol Sci. 2025; 26(3).

PMID: 39940807 PMC: 11817140. DOI: 10.3390/ijms26031038.

Cathelicidins: Opportunities and Challenges in Skin Therapeutics and Clinical Translation.

Dzurova L, Holaskova E, Pospisilova H, Schneider Rauber G, Frebortova J Antibiotics (Basel). 2025; 14(1).

PMID: 39858288 PMC: 11762488. DOI: 10.3390/antibiotics14010001.

Lipopolysaccharide-Neutralizing Peptide Modulates P2X7 Receptor-Mediated Interleukin-1β Release.

Engelhardt J, Klawonn A, Dobbelstein A, Abdelrahman A, Oldenburg J, Brandenburg K ACS Pharmacol Transl Sci. 2025; 8(1):136-145.

PMID: 39816791 PMC: 11729421. DOI: 10.1021/acsptsci.4c00496.

Immunomodulatory peptides: new therapeutic horizons for emerging and re-emerging infectious diseases.

Chatterjee D, Sivashanmugam K Front Microbiol. 2025; 15:1505571.

PMID: 39760081 PMC: 11695410. DOI: 10.3389/fmicb.2024.1505571.

Antimicrobial neuropeptides and their therapeutic potential in vertebrate brain infectious disease.

Li X, Chen K, Liu R, Zheng Z, Hou X Front Immunol. 2024; 15:1496147.

PMID: 39620214 PMC: 11604648. DOI: 10.3389/fimmu.2024.1496147.

References

Wang Z, Wang G . APD: the Antimicrobial Peptide Database. Nucleic Acids Res. 2003; 32(Database issue):D590-2. PMC: 308759. DOI: 10.1093/nar/gkh025. View

Otte J, Zdebik A, Brand S, Chromik A, Strauss S, Schmitz F . Effects of the cathelicidin LL-37 on intestinal epithelial barrier integrity. Regul Pept. 2009; 156(1-3):104-17. DOI: 10.1016/j.regpep.2009.03.009. View

Di Nardo A, Braff M, Taylor K, Na C, Granstein R, McInturff J . Cathelicidin antimicrobial peptides block dendritic cell TLR4 activation and allergic contact sensitization. J Immunol. 2007; 178(3):1829-34. DOI: 10.4049/jimmunol.178.3.1829. View

Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, Gizinski A, Yalavarthi S, Knight J . NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med. 2013; 5(178):178ra40. PMC: 3727661. DOI: 10.1126/scitranslmed.3005580. View

Elkon K, Santer D . Complement, interferon and lupus. Curr Opin Immunol. 2012; 24(6):665-70. DOI: 10.1016/j.coi.2012.08.004. View

Favilli F, Anzilotti C, Martinelli L, Quattroni P, De Martino S, Pratesi F . IL-18 activity in systemic lupus erythematosus. Ann N Y Acad Sci. 2009; 1173:301-9. DOI: 10.1111/j.1749-6632.2009.04742.x. View

Vandamme D, Landuyt B, Luyten W, Schoofs L . A comprehensive summary of LL-37, the factotum human cathelicidin peptide. Cell Immunol. 2012; 280(1):22-35. DOI: 10.1016/j.cellimm.2012.11.009. View

Gage J, Hasu M, Thabet M, Whitman S . Caspase-1 deficiency decreases atherosclerosis in apolipoprotein E-null mice. Can J Cardiol. 2012; 28(2):222-9. DOI: 10.1016/j.cjca.2011.10.013. View

Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang Y, Homey B . Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature. 2007; 449(7162):564-9. DOI: 10.1038/nature06116. View

10.

Doring Y, Drechsler M, Wantha S, Kemmerich K, Lievens D, Vijayan S . Lack of neutrophil-derived CRAMP reduces atherosclerosis in mice. Circ Res. 2012; 110(8):1052-6. DOI: 10.1161/CIRCRESAHA.112.265868. View

11.

Brown K, Poon G, Birkenhead D, Pena O, Falsafi R, Dahlgren C . Host defense peptide LL-37 selectively reduces proinflammatory macrophage responses. J Immunol. 2011; 186(9):5497-505. DOI: 10.4049/jimmunol.1002508. View

12.

Kahlenberg J, Carmona-Rivera C, Smith C, Kaplan M . Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages. J Immunol. 2012; 190(3):1217-26. PMC: 3552129. DOI: 10.4049/jimmunol.1202388. View

13.

Turner J, Cho Y, Dinh N, Waring A, Lehrer R . Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother. 1998; 42(9):2206-14. PMC: 105778. DOI: 10.1128/AAC.42.9.2206. View

14.

Chotjumlong P, Bolscher J, Nazmi K, Reutrakul V, Supanchart C, Buranaphatthana W . Involvement of the P2X7 purinergic receptor and c-Jun N-terminal and extracellular signal-regulated kinases in cyclooxygenase-2 and prostaglandin E2 induction by LL-37. J Innate Immun. 2012; 5(1):72-83. PMC: 6741590. DOI: 10.1159/000342928. View

15.

Schauber J, Gallo R . The vitamin D pathway: a new target for control of the skin's immune response?. Exp Dermatol. 2008; 17(8):633-9. PMC: 2729115. DOI: 10.1111/j.1600-0625.2008.00768.x. View

16.

Lee Y, Lee H, Choi S, Ji J, Song G . Associations between TLR polymorphisms and systemic lupus erythematosus: a systematic review and meta-analysis. Clin Exp Rheumatol. 2012; 30(2):262-5. View

17.

Garcia-Romo G, Caielli S, Vega B, Connolly J, Allantaz F, Xu Z . Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med. 2011; 3(73):73ra20. PMC: 3143837. DOI: 10.1126/scitranslmed.3001201. View

18.

Kaur S, White S, Bartold P . Periodontal disease and rheumatoid arthritis: a systematic review. J Dent Res. 2013; 92(5):399-408. DOI: 10.1177/0022034513483142. View

19.

Hakkim A, Furnrohr B, Amann K, Laube B, Abu Abed U, Brinkmann V . Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci U S A. 2010; 107(21):9813-8. PMC: 2906830. DOI: 10.1073/pnas.0909927107. View

20.

Lai Y, Adhikarakunnathu S, Bhardwaj K, Ranjith-Kumar C, Wen Y, Jordan J . LL37 and cationic peptides enhance TLR3 signaling by viral double-stranded RNAs. PLoS One. 2011; 6(10):e26632. PMC: 3198786. DOI: 10.1371/journal.pone.0026632. View